Related Experiment Video

Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

Development of Ambulatory Oncology Clinical Pharmacy Key Performance Indicators Using a Modified Delphi Consensus

Thomas McFarlane1, Rozhannaa Sothilingam1, Olavo Fernandes2

  • 1University of Waterloo, Kitchener, ON, Canada.

JCO Oncology Practice
|July 30, 2025
PubMed
Abstract

Insights

This study developed 14 evidence-based ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs) through a consensus process. These metrics standardize evaluation and improve patient outcomes in ambulatory oncology pharmacy.

Area of Science:

  • Oncology Pharmacy Practice
  • Health Services Research
  • Quality Improvement

Background:

  • Ambulatory oncology pharmacy practice requires standardized metrics for quality assessment.
  • Existing practices lack a unified approach to evaluating clinical pharmacist activities.

Purpose of the Study:

  • To develop evidence-based ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs).
  • Establish standardized metrics for evaluating ambulatory oncology pharmacist performance.

Main Methods:

  • A systematic, modified Delphi process involving a panel of oncology pharmacists.
  • Environmental scan of Canadian oncology pharmacy practices and literature review.
  • Three Delphi rounds and a virtual meeting to refine 17 candidate AOcpKPIs.

Main Results:

  • Consensus was reached on 14 ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs).
  • Key indicators encompass clinical order review, patient education, medication adherence, and drug therapy problem management.
  • The developed AOcpKPIs enable standardized evaluation, benchmarking, and outcome improvement.

Conclusions:

  • The study established a foundational set of quality metrics for ambulatory oncology pharmacy.
  • Consensus-based AOcpKPIs support enhanced patient care, accountability, and continuous quality improvement.
  • Implementation of AOcpKPIs can elevate practice standards and foster evidence-based patient outcomes.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

17.2K

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K